Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease

Biochemical Pharmacology

Volumn 90, Issue 4, 2014, Pages 338-348

  Quach, Nhat D ^a   Arnold, Robert D ^b   Cummings, Brian S ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Cell signaling; Interactomes; Liposomes; Nanoparticles

Indexed keywords

BINDING PROTEIN; SECRETORY PHOSPHOLIPASE A2; ENZYME INHIBITOR; LIPOSOME; NANOPARTICLE;

DISEASE COURSE; ENZYME REGULATION; GENETIC REGULATION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; CARDIOVASCULAR DISEASE; CELL SIGNALING; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; INFLAMMATION; INTERACTOMES; METABOLISM; MOLECULAR GENETICS; NEOPLASM; PHOSPHOLIPASE A(2) RECEPTOR; SECRETORY PHOSPHOLIPASE A(2); SEPSIS; SEQUENCE HOMOLOGY;

CELL SIGNALING; INTERACTOMES; LIPOSOMES; NANOPARTICLES; PHOSPHOLIPASE A(2) RECEPTOR; SECRETORY PHOSPHOLIPASE A(2);

AMINO ACID SEQUENCE; CARDIOVASCULAR DISEASES; ENZYME INHIBITORS; HUMANS; INFLAMMATION; MOLECULAR SEQUENCE DATA; NEOPLASMS; PHOSPHOLIPASES A2, SECRETORY; SEPSIS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84904638907     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.05.022     Document Type: Note

References (112)

1. B.S. Cummings, J. McHowat, and R.G. Schnellmann Phospholipase A(2)s in cell injury and death J Pharmacol Exp Ther 294 2000 793 799 (Pubitemid 30666826)
2. E.A. Dennis, J. Cao, Y.H. Hsu, V. Magrioti, and G. Kokotos Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention Chem Rev 111 2011 6130 6185
3. M. Murakami, Y. Taketomi, Y. Miki, H. Sato, T. Hirabayashi, and K. Yamamoto Recent progress in phospholipase A research: from cells to animals to humans Prog Lipid Res 50 2011 152 192
4. J. Nelson, E. Gibbons, K.R. Pickett, M. Streeter, A.O. Warcup, and C.H.Y. Yeung et al. Relationship between membrane permeability and specificity of human secretory phospholipase A(2) isoforms during cell death Biochim Biophys Acta 1808 2011 1913 1920
5. B.S. Cummings, J. McHowat, and R.G. Schnellmann Role of an endoplasmic reticulum Ca(2+)-independent phospholipase A(2) in oxidant-induced renal cell death Am J Physiol Renal Physiol 283 2002 F492 F498
6. C.H. Chen Platelet-activating factor acetylhydrolase: is it good or bad for you Curr Opin Lipidol 15 2004 337 341
7. M. Hiraoka, A. Abe, Y. Lu, K. Yang, X. Han, and R.W. Gross et al. Lysosomal phospholipase A2 and phospholipidosis Mol Cell Biol 26 2006 6139 6148 (Pubitemid 44204532)
8. K. Jaworski, M. Ahmadian, R.E. Duncan, E. Sarkadi-Nagy, K.A. Varady, and M.K. Hellerstein et al. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency Nat Med 15 2009 159 168
9. B.S. Cummings Phospholipase A2 as targets for anti-cancer drugs Biochem Pharmacol 74 2007 949 959
10. Gr Lambeau, and M.H. Gelb Biochemistry and physiology of mammalian secreted phospholipases A2 Annu Rev Biochem 77 2008 495 520
11. S. Chakraborti Phospholipase A2 isoforms: a perspective Cell Signal 15 2003 637 665
12. G. Lambeau, and M.H. Gelb Biochemistry and physiology of mammalian secreted phospholipases A2 Annu Rev Biochem 77 2008 495 520
13. E. Valentin, A.G. Singer, F. Ghomashchi, M. Lazdunski, M.H. Gelb, and G. Lambeau Cloning and recombinant expression of human group IIF-secreted phospholipase A(2) Biochem Biophys Res Commun 279 2000 223 228
14. Y.H. Pan, B.Z. Yu, A.G. Singer, F. Ghomashchi, G. Lambeau, and M.H. Gelb et al. Crystal structure of human group X secreted phospholipase A2. Electrostatically neutral interfacial surface targets zwitterionic membranes J Biol Chem 277 2002 29086 29093
15. S.H. Edwards, D. Thompson, S.F. Baker, S.P. Wood, and D.C. Wilton The crystal structure of the H48Q active site mutant of human group IIA secreted phospholipase A2 at 1.5 A resolution provides an insight into the catalytic mechanism Biochemistry 41 2002 15468 15476 (Pubitemid 36062452)
16. A.G. Singer, F. Ghomashchi, C. Le Calvez, J. Bollinger, S. Bezzine, and M. Rouault et al. Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2 J Biol Chem 277 2002 48535 48549 (Pubitemid 35470814)
17. T.J. Nevalainen, G.G. Graham, and K.F. Scott Antibacterial actions of secreted phospholipases A2. Review Biochim Biophys Acta 1781 2008 1 9
18. I. Jemel, H. Ii, R.C. Oslund, C. Payré, A-S. Dabert-Gay, and D. Douguet et al. Group X secreted phospholipase A2 proenzyme is matured by a furin-like proprotein convertase and releases arachidonic acid inside of human HEK293 cells J Biol Chem 286 2011 36509 36521
19. M. Murakami, T. Kambe, S. Shimbara, S. Yamamoto, H. Kuwata, and I. Kudo Functional association of type IIA secretory phospholipase A(2) with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway J Biol Chem 274 1999 29927 29936
20. M. Murakami, Y. Taketomi, H. Sato, and K. Yamamoto Secreted phospholipase A2 revisited J Biochem 150 2011 233 255
21. M. Murakami, I. Kudo, and K. Inoue In vivo release and clearance of rat platelet phospholipase A2 Biochim Biophys Acta 1005 1989 270 276 (Pubitemid 19241554)
22. J. Sribar, and I. Krizaj Secreted phospholipases A2 - not just enzymes Acta Chim Slov 58 2011 678 688
23. L.J. Tong, L.W. Dong, and M.S. Liu GTP-binding protein mediated phospholipase A2 activation in rat liver during the progression of sepsis Mol Cell Biochem 189 1998 55 61
24. E. Boilard, Y. Lai, K. Larabee, B. Balestrieri, F. Ghomashchi, and D. Fujioka et al. A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis EMBO Mol Med 2 2010 172 187
25. R.S. Rosenson, and E. Hurt-Camejo Phospholipase A2 enzymes and the risk of atherosclerosis Eur Heart J 33 2012 2899 2909
26. S. Yamashita, M. Ogawa, K. Sakamoto, T. Abe, H. Arakawa, and J. Yamashita Elevation of serum group II phospholipase A2 levels in patients with advanced cancer Clin Chim Acta 228 1994 91 99 (Pubitemid 24264679)
27. Q. Dong, M. Patel, K.F. Scott, G.G. Graham, P.J. Russell, and P. Sved Oncogenic action of phospholipase A2 in prostate cancer Cancer Lett 240 2006 9 16 (Pubitemid 44037166)
28. M. Murakami, S. Masuda, S. Shimbara, Y. Ishikawa, T. Ishii, and I. Kudo Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A(2) J Biol Chem 280 2005 24987 24998 (Pubitemid 40934591)
29. P. Sved, K.F. Scott, D. McLeod, N.J. King, J. Singh, and T. Tsatralis et al. Oncogenic action of secreted phospholipase A2 in prostate cancer Cancer Res 64 2004 6934 6940 (Pubitemid 39331002)
30. J. Jiang, B.L. Neubauer, J.R. Graff, M. Chedid, J.E. Thomas, and N.W. Roehm et al. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma Am J Pathol 160 2002 667 671 (Pubitemid 34160344)
31. J.R. Graff, B.W. Konicek, J.A. Deddens, M. Chedid, B.M. Hurst, and B. Colligan et al. Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade Clin Cancer Res 7 2001 3857 3861 (Pubitemid 34044601)
32. S.Y. Leung, X. Chen, K.M. Chu, S.T. Yuen, J. Mathy, and J. Ji et al. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis Proc Natl Acad Sci U S A 99 2002 16203 16208 (Pubitemid 35462773)
33. M. Nakanishi, D.C. Montrose, P. Clark, P.R. Nambiar, G.S. Belinsky, and K.P. Claffey et al. Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis Cancer Res 68 2008 3251 3259
34. B.B. Boyanovsky, and N.R. Webb Biology of secretory phospholipase A2 Cardiovasc Drugs Ther 23 2009 61 72
35. A.G. Buckland, E.L. Heeley, and D.C. Wilton Bacterial cell membrane hydrolysis by secreted phospholipases A(2): a major physiological role of human group IIa sPLA(2) involving both bacterial cell wall penetration and interfacial catalysis Biochim Biophys Acta 1484 2000 195 206 (Pubitemid 30175969)
36. J.O. Gronroos, V.J. Laine, and T.J. Nevalainen Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections J Infect Dis 185 2002 1767 1772 (Pubitemid 34615471)
37. S. Yamashita, J. Yamashita, and M. Ogawa Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency Br J Cancer 69 1994 1166 1170 (Pubitemid 24161881)
38. M. Menschikowski, A. Hagelgans, U. Schuler, S. Froeschke, A. Rosner, and G. Siegert Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkers Pathol Oncol Res 19 2013 839 846
39. X. Wang, C.-J. Huang, G.-Z. Yu, J.-J. Wang, R. Wang, and Y.-M. Li et al. Expression of group IIA phospholipase A2 is an independent predictor of favorable outcome for patients with gastric cancer Hum Pathol 44 2013 2020 2027
40. R. Sasisekharan, Z. Shriver, G. Venkataraman, and U. Narayanasami Roles of heparan-sulphate glycosaminoglycans in cancer Nat Rev Cancer 2 2002 521 528 (Pubitemid 37328933)
41. N.M. Munoz, A.Y. Meliton, J.P. Arm, J.V. Bonventre, W. Cho, and A.R. Leff Deletion of secretory group V phospholipase A2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice J Immunol 179 2007 4800 4807
42. N.M. Munoz, A.Y. Meliton, L.N. Meliton, S.M. Dudek, and A.R. Leff Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice Am J Physiol Lung Cell Mol Physiol 296 2009 L879 L887
43. A. Pucer, V. Brglez, C. Payre, J. Pungercar, G. Lambeau, and T. Petan Group X secreted phospholipase A(2) induces lipid droplet formation and prolongs breast cancer cell survival Mol Cancer 12 2013 111
44. M. Hiyoshi, J. Kitayama, S. Kazama, Y. Taketomi, M. Murakami, and N.H. Tsuno et al. The expression of phospholipase A2 group X is inversely associated with metastasis in colorectal cancer Oncol Lett 5 2013 533 538
45. L. Zhou, and A. Nilsson Sources of eicosanoid precursor fatty acid pools in tissues J Lipid Res 42 2001 1521 1542 (Pubitemid 33020085)
46. M. Bruegel, U. Ludwig, A. Kleinhempel, S. Petros, L. Kortz, and U. Ceglarek et al. Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients Crit Care Med 40 2012 1478 1486
47. M. Murakami Lipid mediators in life science Exp Anim 60 2011 7 20
48. S. Beck, G. Lambeau, K. Scholz-Pedretti, M.H. Gelb, M.J. Janssen, and S.H. Edwards et al. Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation J Biol Chem 278 2003 29799 29812 (Pubitemid 36962367)
49. T. Mutoh, and J. Chun Lysophospholipid activation of G protein-coupled receptors Subcell Biochem 49 2008 269 297
50. R.D. Ye Regulation of nuclear factor kappaB activation by G-protein-coupled receptors J Leukoc Biol 70 2001 839 848 (Pubitemid 33151122)
51. J. Martel-Pelletier, D. Lajeunesse, P. Reboul, and J.P. Pelletier Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs Ann Rheum Dis 62 2003 501 509 (Pubitemid 36606279)
52. S. Sarrazin, W.C. Lamanna, and J.D. Esko Heparan sulfate proteoglycans Cold Spring Harb Perspect Biol 3 2011 1 33
53. R. Dua, and W. Cho Inhibition of human secretory class II phospholipase A2 by heparin Eur J Biochem 221 1994 481 490 (Pubitemid 24120594)
54. D. Vindrieux, A. Augert, C.A. Girard, D. Gitenay, H. Lallet-Daher, and C. Wiel et al. PLA2R1 mediates tumor suppression by activating JAK2 Cancer Res 73 2013 6334 6345
55. A. Augert, C. Payré, Y. de Launoit, J. Gil, G. Lambeau, and D. Bernard The M-type receptor PLA2R regulates senescence through the p53 pathway EMBO Rep 10 2009 271 277
56. P. Sartipy, G. Bondjers, and E. Hurt-Camejo Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixes Arterioscler Thromb Vasc Biol 18 1998 1934 1941 (Pubitemid 28565757)
57. M.B. Diccianni, L.R. McLean, W.D. Stuart, M.J. Mistry, C.M. Gil, and J.A. Harmony Porcine pancreatic phospholipase A2 isoforms: differential regulation by heparin Biochim Biophys Acta 1082 1991 85 93
58. W. Koenig, C.Y. Vossen, Z. Mallat, H. Brenner, J. Benessiano, and D. Rothenbacher Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease Eur Heart J 30 2009 2742 2748
59. Y. Wei, S.P. Epstein, S. Fukuoka, N.P. Birmingham, and X.M. Li Asbell PA. sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model Invest Ophthalmol Vis Sci 52 2011 4780 4788
60. J.A. Yu, S. Kalatardi, J. Dohse, M.R. Sadaria, X. Meng, and D.A. Fullerton et al. Group IIa sPLA2 inhibition attenuates NF-kappaB activity and promotes apoptosis of lung cancer cells Anticancer Res 32 2012 3601 3607
61. Q. Fan, M. Paradon, C. Salvat, G. Bereziat, and J.L. Olivier C/EBP factor suppression of inhibition of type II secreted phospholipase A2 promoter in HepG2 cells: possible role of single-strand binding proteins Mol Cell Biol 17 1997 4238 4248 (Pubitemid 27318100)
62. L. Ravaux, C. Denoyelle, C. Monne, I. Limon, M. Raymondjean, and K. El Hadri Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6 Mol Cell Biol 27 2007 8374 8387 (Pubitemid 350234248)
63. J.A. Van Ginderachter, S. Meerschaut, Y. Liu, L. Brys, K. De Groeve, and G. Hassanzadeh Ghassabeh et al. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer Blood 108 2006 525 535 (Pubitemid 44061352)
64. M. Menschikowski, A. Hagelgans, E. Gussakovsky, H. Kostka, E.L. Paley, and G. Siegert Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms Neoplasia 10 2008 279 286 (Pubitemid 351328586)
65. T. Paranjape, F.J. Slack, and J.B. Weidhaas MicroRNAs: tools for cancer diagnostics Gut 58 2009 1546 1554
66. T. Yano, D. Fujioka, Y. Saito, T. Kobayashi, T. Nakamura, and J.E. Obata et al. Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury Cardiovasc Res 90 2011 335 343
67. W. Cho Structure, function, and regulation of group V phospholipase A(2) Biochim Biophys Acta 1488 2000 48 58
68. M.F. Hsu, M.C. Lu, L.T. Tsao, Y.H. Kuan, C.C. Chen, and J.P. Wang Mechanisms of the influence of magnolol on eicosanoid metabolism in neutrophils Biochem Pharmacol 67 2004 831 840
69. K. Hanasaki, and H. Arita Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2 Prostaglandins Other Lipid Mediat 68-69 2002 71 82 (Pubitemid 35247388)
70. D. Bernard, and D. Vindrieux PLA2R1: expression and function in Cancer Biochim Biophys Acta 1846 2014 40 44
71. E. Zvaritch, G. Lambeau, and M. Lazdunski Endocytic properties of the M-type 180-kDa receptor for secretory phospholipases A2 J Biol Chem 271 1996 250 257 (Pubitemid 26026586)
72. R.J. Glassock The pathogenesis of membranous nephropathy: evolution and revolution Curr Opin Nephrol Hypertens 21 2012 235 242
73. H. Mishina, K. Watanabe, S. Tamaru, Y. Watanabe, D. Fujioka, and S. Takahashi et al. Lack of phospholipase A2 receptor increases susceptibility to cardiac rupture after myocardial infarction Circ Res 114 2014 493 504
74. J. Gutierrez, and E. Brandan A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation Mol Cell Biol 30 2010 1634 1649
75. K. Forsten-Williams, C.L. Chu, M. Fannon, J.A. Buczek-Thomas, and M.A. Nugent Control of growth factor networks by heparan sulfate proteoglycans Ann Biomed Eng 36 2008 2134 2148
76. A. Wagle, V. Patki, S. Desai, and R. Mulherkar Heparin inhibits enhancing factor/phospholipase A2 activity and its binding to the cell surface J Biosci 22 1997 537 543 (Pubitemid 28123246)
77. M.M. Thwin, R.L. Satish, S.T. Chan, and P. Gopalakrishnakone Functional site of endogenous phospholipase A2 inhibitor from python serum Eur J Biochem 269 2002 719 727
78. D.W. Nitzan, U. Nitzan, P. Dan, and S. Yedgar The role of hyaluronic acid in protecting surface-active phospholipids from lysis by exogenous phospholipase A(2) Rheumatology 40 2001 336 340
79. R.C. Reid Inhibitors of secretory phospholipase A2 group IIA Curr Med Chem 12 2005 3011 3026 (Pubitemid 41672489)
80. N. Degousee, F. Ghomashchi, E. Stefanski, A. Singer, B.P. Smart, and N. Borregaard et al. Groups IV, V, and X phospholipases A2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis J Biol Chem 277 2002 5061 5073 (Pubitemid 34968547)
81. D.W. Snyder, N.J. Bach, R.D. Dillard, S.E. Draheim, D.G. Carlson, and N. Fox et al. Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: a new class of anti-inflammatory drugs, SPI J Pharmacol Exp Ther 288 1999 1117 1124 (Pubitemid 29254149)
82. R.S. Rosenson After FRANCIS: next steps in the clinical evaluation of varespladib methyl Future Cardiol 7 2011 11 18
83. S.J. Nicholls, J.J. Kastelein, G.G. Schwartz, D. Bash, R.S. Rosenson, and M.A. Cavender et al. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial J Am Med Assoc 311 2014 252 262
84. E. Boilard, M. Rouault, F. Surrel, C. Le Calvez, S. Bezzine, and A. Singer et al. Secreted phospholipase A2 inhibitors are also potent blockers of binding to the M-type receptor Biochemistry 45 2006 13203 13218 (Pubitemid 44707681)
85. S. Chen, L. Yao, and T.J. Cunningham Secreted phospholipase A2 involvement in neurodegeneration: differential testing of prosurvival and anti-inflammatory effects of enzyme inhibition PLoS ONE 7 2012 e39257
86. J.X. Zhang, and A. Khademhosseini Emerging micro- and nanotechnologies in cancer diagnosis and therapy Biomed Microdevices 15 2013 579 581
87. S.S. Jensen, T.L. Andresen, J. Davidsen, P. Høyrup, S.D. Shnyder, and M.C. Bibby et al. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids Mol Cancer Ther 3 2004 1451 1458 (Pubitemid 39562590)
88. G. Zhu, Y. Alhamhoom, B.S. Cummings, and R.D. Arnold Synthesis of lipids for development of multifunctional lipid-based drug-carriers Bioorg Med Chem Lett 21 2011 6370 6375
89. J.N. Mock, L.J. Costyn, S.L. Wilding, R.D. Arnold, and B.S. Cummings Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer Integr Biol 5 2013 172 182
90. K. Jorgensen, J. Davidsen, and O.G. Mouritsen Biophysical mechanisms of phospholipase A2 activation and their use in liposome-based drug delivery FEBS Lett 531 2002 23 27 (Pubitemid 35232779)
91. G. Zhu, J.N. Mock, I. Aljuffali, B.S. Cummings, and R.D. Arnold Secretory phospholipase A(2) responsive liposomes J Pharm Sci 100 2011 3146 3159
92. J.M. van den Hoven, S.R. Van Tomme, J.M. Metselaar, B. Nuijen, J.H. Beijnen, and G. Storm Liposomal drug formulations in the treatment of rheumatoid arthritis Mol Pharm 8 2011 1002 1015
93. J.G. Cash, D.G. Kuhel, C. Goodin, and D.Y. Hui Pancreatic acinar cell-specific overexpression of group 1B phospholipase A2 exacerbates diet-induced obesity and insulin resistance in mice Int J Obes (Lond) 35 2011 877 881
94. Y. Wei, A. Pinhas, Y. Liu, S. Epstein, J. Wang, and P. Asbell Isoforms of secretory group two phospholipase A (sPLA2) in mouse ocular surface epithelia and lacrimal glands Invest Ophthalmol Vis Sci 53 2012 2845 2855
95. M. Ito, Y. Ishikawa, H. Kiguchi, K. Komiyama, M. Murakami, and I. Kudo et al. Distribution of type V secretory phospholipase A2 expression in human hepatocytes damaged by liver disease J Gastroenterol Hepatol 19 2004 1140 1149 (Pubitemid 39371256)
96. A. Igarashi, Y. Shibata, K. Yamauchi, D. Osaka, N. Takabatake, and S. Abe et al. Gly80Ser polymorphism of phospholipase A2-IID is associated with cytokine inducibility in A549 cells Respiration 78 2009 312 321
97. G.G. Anderson, and J.F. Morrison Molecular biology and genetics of allergy and asthma Arch Dis Child 78 1998 488 496 (Pubitemid 28237397)
98. M.S. Silverberg, J.H. Cho, J.D. Rioux, D.P. McGovern, J. Wu, and V. Annese et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study Nat Genet 41 2009 216 220
99. Z. Liu, X. Lu, H. Wang, X.J. You, Q.X. Gao, and Y.H. Cui Group II subfamily secretory phospholipase A2 enzymes: expression in chronic rhinosinusitis with and without nasal polyps Allergy 62 2007 999 1006 (Pubitemid 47220964)
100. M. Murakami, K. Yoshihara, S. Shimbara, G. Lambeau, M.H. Gelb, and A.G. Singer et al. Cellular arachidonate-releasing function and inflammation- associated expression of group IIF secretory phospholipase A2 J Biol Chem 277 2002 19145 19155 (Pubitemid 34952481)
101. C.M. Mounier, D. Wendum, E. Greenspan, J.F. Flejou, D.W. Rosenberg, and G. Lambeau Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate Br J Cancer 98 2008 587 595 (Pubitemid 351214519)
102. H. Sato, R. Kato, Y. Isogai, G. Saka, M. Ohtsuki, and Y. Taketomi et al. Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis J Biol Chem 283 2008 33483 33497
103. V.M. Wang, R.B. Rosen, C.B. Meyerle, S.K. Kurup, D. Ardeljan, and E. Agron et al. Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration Mol Vis 18 2012 2578 2585
104. H. Kurihara, S. Matsuzaki, M. Tamura, H. Sugimoto, T. Tsukahara, and H. Yamazaki alpha-Difluoromethylornithine increases the anti-tumor effect of cis-diamminedichloroplatinum in G-XII rat glioma Neurol Med Chir (Tokyo) 35 1995 215 220
105. T.J. Nevalainen, L.I. Eerola, E. Rintala, V.J. Laine, G. Lambeau, and M.H. Gelb Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum Biochim Biophys Acta 1733 2005 210 223 (Pubitemid 40603664)
106. T.J. Nevalainen, I. Morgado, and J.C. Cardoso Identification of novel phospholipase A2 group IX members in metazoans Biochimie 95 2013 1534 1543
107. R.C. Oslund, N. Cermak, C.L. Verlinde, and M.H. Gelb Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA Bioorg Med Chem Lett 18 2008 5415 5419
108. H. Fraser, C. Hislop, R.M. Christie, H.L. Rick, C.A. Reidy, and M.L. Chouinard et al. Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice J Cardiovasc Pharmacol 53 2009 60 65
109. R.C. Oslund, N. Cermak, and M.H. Gelb Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2 J Med Chem 51 2008 4708 4714
110. S. Levick, D. Loch, B. Rolfe, R.C. Reid, D.P. Fairlie, and S.M. Taylor et al. Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A2 in young spontaneously hypertensive rats J Immunol 176 2006 7000 7007 (Pubitemid 43787880)
111. M. Touaibia, A. Djimde, F. Cao, E. Boilard, S. Bezzine, and G. Lambeau et al. Inhibition of secreted phospholipase A2. 4-Glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities J Med Chem 50 2007 1618 1626 (Pubitemid 46564382)
112. T.C. Moon, Z. Quan, J. Kim, H.P. Kim, I. Kudo, and M. Murakami et al. Inhibitory effect of synthetic C-C biflavones on various phospholipase A2s activity Bioorg Med Chem 15 2007 7138 7143 (Pubitemid 47451783)